|Bid||0.1283 x 29200|
|Ask||0.1290 x 900|
|Day's range||0.1238 - 0.1330|
|52-week range||0.0680 - 1.1700|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||N/A|
|Earnings date||08 Nov 2022 - 14 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||4.00|
The heavy selling pressure might have exhausted for Allena Pharmaceuticals, Inc. (ALNA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Allena Pharmaceuticals, Inc. (ALNA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Allena Pharmaceuticals (ALNA) has been struggling lately, but the selling pressure may be coming to an end soon.